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Abstract
Objectives: To establish whether there is a high enough risk of bleeding in patients who take oral anticoagulants, 
such that it would justify not using oral anticoagulants when performing a dental extraction, as well as if the rea-
son for and anatomical location of the extraction increases such risk.
Study Design: We performed a bibliographic search in order to carry out a meta-analytic study using descriptive 
statistics.
Results: We compiled a sample of 1194 patients from the articles selected. Of these patients, a total of 2392 sim-
ple, serial surgical extractions were performed; none of the patients interrupted their anticoagulant treatment 
with warfarin sodium.  Of the sample, 83 patients presented a certain degree of bleeding; in 77 of such cases, the 
bleeding was controlled with local hemostasis, whereas 6 patients required their dose of oral anticoagulants to be 
adjusted. There was a higher incidence of bleeding in patients presenting a periodontal pathology, compared to 
deep caries and pericoronitis.
Conclusions: Patients being treated with oral anticoagulants represent a risk that we should be aware of, but local 
hemostasis has proven to be effective when performing extractions, provided that the INR value is less than 4. 
There is an increased incidence of bleeding in patients with periodontal problems, due to the greater presence of 
inflammation in the soft tissues. If the extraction is performed in the maxilla, the incidence of hemorrhagic com-
plications is slightly higher than in the mandible, although this difference is considered to be insignificant.
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Introduction
Oral anticoagulants (OAC) are widely used in the treat-
ment and prevention of deep thrombosis and pulmonary 
embolism in order to prevent arterial thromboembolism 
in patients with auricular fibrillation and/or a cardiac 
valvular prosthesis (1).
Oral anticoagulants inhibit the plasma phase of coagula-
tion, whether by acting on the hepatic synthesis of coa-
gulation factors or by impeding already formed factors 
(heparins) from acting. Thus, the term anticoagulants 
can be defined as oral vitamin K antagonists (1). OACs 
can be derived from coumarin or indandiones; those de-
rived from coumarin are the most frequently used, and 
within this group, warafin sodium (Coumadin®) and 
acenocoumarol (Sintrom®) are the most common.  
They are well-tolerated drugs and have a rapid oral ab-
sorption, with plasma peaks being reached at the time 
of ingestion, although reducing the coagulation factors 
takes place 48-72 hours after taking the drug (2). War-
farin has an average life of 48-72 hours and acenocou-
marol has an average life of 8-10 hours; thus, the effects 
of warfarin last longer, both in the induction as well as 
in the disappearance of the therapeutic action.
In 1978, the World Health Organization (WHO) recom-
mended standardizing the prothrombin time (PT) and in 
1983, it introduced the INR (International Normalized 
Ratio), publishing recommendations for calculating 
the degree of anticoagulation (3) [INR = (patient PT/
mean normal PT) ISI]. The mean normal PT is the PT 
based on the geometric average of fresh plasma from 20 
healthy patients; ISI is the International Sensitivity In-
dex (3); and the PT is standardized by means of this for-
mula, comparing it independently of the thromboplastin 
used by the different laboratories, thus offering a higher 
reliability in monitoring treatment with oral anticoa-
gulants. At the same time, the international cardiology 
and hematology societies (1-3) have made recommenda-
tions about the therapeutic levels of anticoagulation at 
which patients must be maintained, depending on the 
existing pathology, with the INR value ranging from 2 
to 3.5 (2,4).   There is a strong correlation between the 
INR value and the risk of bleeding, but there are also 
other factors that can make bleeding more likely to oc-
cur. These factors must also be taken into account, such 
as the underlying clinical pathology (5) (ex. hepatic ill-
ness, alteration in the osseous medulla, anemia, malab-
sorption, kidney disease) and taking certain drugs that 
intensify their effects. Therefore, it would be recom-
mendable to perform more frequent analytical controls 
after starting a new medication (4,5). 
Material and Methods
In the present meta-analytic study, we performed a 
bibliographic search in the PubMed and Medline data-
bases, using the keywords: oral surgery, anticoagulation 
and coumarin. From this search, we obtained 50 referenc-
es from specialized journals, selecting 12 of these for 
carrying out the meta-analysis. As inclusion criteria, the 
anticoagulant therapy had to consist of using oral antico-
agulants and not antiplatelet drugs, and such treatment 
with OACs could not be suspended at the time of per-
forming the extractions.
The variables taken into account were: the patient’s sex, 
INR value, age, presence of bleeding—whether imme-
diately or later during the post-extraction period—and 
the local measurements used for controlling hemostasis. 
We also examined other variables during the study, such 
as whether the extraction was carried out in the maxilla 
or the mandible, and the reason for the extraction. 
A table was created for all of these variables (Table 1), 
where the different variables analyzed in the study were 
recorded, subsequently carrying out a descriptive statis-
tical study in order to obtain our results.
Results
In the articles selected, the total number of patients 
studied was 1194, there being a total of 2392 extrac-
tions performed on these patients.  The patients ranged 
in age from 7 to 92 years old, with a mean age of 64.3 
years old.
All of the patients were prescribed long-term anticoagu-
lant treatment with warfarin sodium. The anticoagulant 
treatment was not suspended in any of the cases and the 
INR value was maintained within therapeutic ranges—
the mean INR being 2.6, with a range of 0.9-5.0.
On a sample of 1024 patients, the patients under treat-
ment were predominantly male—given that the sex 
was not recorded by the authors for the other 170 pa-
tients, there being 605 males (59.08%) and 419 females 
(40.92%). The presence of bleeding depending on the 
patient’s gender could not be studied, given that the au-
thors did not record this variable for the patients who 
suffered hemorrhagic complications. 
A total of 2,392 simple, serial surgical extractions were 
performed, amounting to an average of 2 extractions 
per patient, with a range of 1 to 5 extractions per pa-
tient.  Of the 1194 patients, 83 (6.95%) presented some 
degree of bleeding, 6 (8.57%) of which required their 
dose of OACs to be modified by their doctor. The rest 
of the patients were controlled using local measures. In 
48 patients (57.83%), the bleeding was controlled by ap-
plying compression with gauze on the wound; whereas 
in 21 patients (25.30%), the bleeding was controlled 
by applying tranexamic acid on the wound or gelatin 
sponges and compression. Curettage of the alveolus was 
performed in addition to using dense autologous fibrin 
glue and compression in 7 patients (8.43%), 2 patients 
(2.40%) required resuturing, and electrocoagulation 
was applied in only one case (1.20%). 
In the patients who presented post-extraction bleeding, 
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the range of age varied from 24 to 85 years old, with the 
mean age being 64.74 years old. The range of INR value 
varied from 1.45 to 7.6—the mean INR value being 2.67 
(Table 2), with 25 patients presenting persistent bleed-
ing, 29 presenting moderate bleeding and 29 presenting 
light and intermittent bleeding.  Bleeding occurred in 
the patients during the immediate post-operative period 
and continued for up to 10 days afterward. 
With respect to whether the post-extraction bleeding is 
related to the anatomical location of the extraction, we 
were only able to study 211 patients, given that this data 
was not recorded for the rest of the patients.  A total of 
318 extractions were carried out in the maxilla and 280 
in the mandible, with bleeding present in 24 extractions 
in the maxilla and in 15 extractions in the mandible, 
which represents a 7.54% incidence of bleeding in the 
maxilla and a 5.35% incidence of bleeding in the man-
dible. 
With respect to the reason for the extraction, the study 
was carried out on 554 patients, which amounted to a 
total of 1,225 extractions. The most common cause of 
the extraction was due to a periodontal problem in 660 
of the extractions (53,87%), followed by deep caries 
in 507 of the extractions (41.38%), pericoronitis in 49 
of the extractions (3.91%), and unspecified reasons in 
4 of the extractions (0.32%). Bleeding was present in 
29 patients, with the majority of such incidents being 
related to a periodontal problem, as was the case with 
20 patients, followed by deep caries in 7 patients and 
periocoronitis in 2 patients.
Discussion
In the present study, it was observed that post-extrac-
tion bleeding can be controlled by using local measures, 
provided that the protocol for caring for a patient on an-
ticoagulant treatment is followed: evaluate the risk of 
thromboembolism / bleeding, use the most atraumatic 
Table 2.  INR Range-types of bleeding.
Table 1. Patients undergoing teeth extractions under anticoagulant therapy.  Max.( Maxillar), Mand.(Mandible), P (Periodontitis), C (Car-
ies), AFA (Autologous Fibrin Adhesive). 
INR Range Patients LightBleeding 
Mild
Bleeding 
Persistent 
bleeding 
1.4-2.5 23 11 8 4 
2.51-3.5 35 11 12 12 
>3.5 25  7  9  9 
Authors Patients Teeth extracted Max Mand 
Gender INR 
(mean)
Age
(mean)
Reason for 
extraction Hemostatic means Bleeding M F 
Campbell JH 
et al.(6) 12 38 14 24   
1.2-2.9 
(2.0) 
Oxidized cellulose 
Tranexamic acid 1 patient 
Carter  G, 
Goss A.(7) 85 201 90 111 54 31 (2.8) 
21-86
(65.7) 
P  88 
Deep C 109 
Others  4 
Tranexamic acid 3 patients 
Bodner L et 
al.(8) 69 188     1.0-5.0   Fibrin sealant 3 patients 
Martinowitz 
U et al.(9) 40 63     
2.5-4.5 
(3.25) 
32-75
(55)
Biological adhesive 
(Beriplast) 1 patient 
Della Valle A 
et al.(10) 40 147   22 18 2.0-4.0 43-66  Platelet-rich plasma 18 patients 
Salam S et 
al.(11) 150 279   92 58 
0.9-4.2 
(2.5) 
33-92
(66.1)  Surgicel
® 10 patients 
Ferrieri GB 
et al.(12) 239 314   
13
5
10
4
3-5.4 
(2.5) 
27-89
(67.8)  Tranexamic acid 5 patients 
Evans IL et 
al.(13) 57 69   36 21 
1.2-4-7 
(2.5) 
36-92
(67)  Surgicel
® 15 patients 
Devani  P  et 
al.(14) 33 69   15 18 (2.7) 
30-82
(64.6)  Surgicel
® 1  patient 
Morimoto Y et 
al.(15) 270 513   
16
6
10
4 1.5-3.7 
7-91
(60.5) 
219 Marginal P  
246 Periapical P 
48  pericoronitis 
 11 patients 
Carter G et 
al.(16) 49 152     2.1-4.0 
24-85
(65)
60 P 
92 Deep C 
Tranexamic acid 
AFA 2 patients 
Blinder D et 
al.(17) 150 359 214 145 85 65 
1.5-4.0 
(2.7) 
35-90
(64)
293 P 
60 Deep C 
Gelatin sponge, 
AFA 
Tranexamic acid 
13 patients 
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technique possible and provide the patient with post-
operative care instructions.
Performing extractions in patients under anticoagulant 
treatment is a safe procedure, even with elevated INR 
values, provided that these values do not exceed a maxi-
mum of 4. 
This meta-analytic study only included patients who 
had neither suspended nor reduced their treatment with 
anticoagulants, a procedure that is accepted by the lar-
ge majority of authors (4, 6-12, 18,19).  Other authors 
such as Devani et al. (14) included a control group in which 
they suspended the anticoagulant treatment with warfarin 
sodium 2 days before the procedure and resumed the an-
ticoagulant treatment the day after the procedure, using 
Surgicel® and placing a suture in all of the patients. In 
their study, bleeding complications were present in one 
patient in each group, which was controlled by local 
measures.
Another similar study was conducted by �vans et al. 
(13), who followed the same procedure when suspend-
ing and resuming the warfarin sodium, with the range 
of INR value being between 2 and 4 in the group that 
continued the treatment and less than 2 in the group 
that suspended the treatment. The incidence of blee-
ding was 24% in patients who continued treatment with 
OACs and 16% in patients who suspended the treat-
ment. This difference was considered to be insignificant 
and the bleeding was controlled by applying pressure 
with gauze. Campbell et al. (6) compared patients with 
and without suspension of OACs with patients who had 
never taken OACs, not specifying additional measures 
for controlling the post-operative bleeding in any of the 
patients, finding that there were no differences in the 
bleeding during the procedure. 
As for authors who are against suspending treatment 
with OACs, we may refer to the data obtained by Wahl 
(18) on the post-operative management of patients trea-
ted with anticoagulants. Wahl analyzed 2014 proce-
dures of oral surgery. Serious bleeding only occurred 
in 12 procedures, and of these, 5 of the patients pre-
sented an INR above the therapeutic range. In addition, 
he recorded 493 patients who suspended treatment with 
warfarin sodium; five of these patients developed a seri-
ous thromboembolic problem, leading to death in 4 of 
these patients, concluding that the risk of bleeding after 
an oral procedure is not high enough to raise the risk of 
thromboembolism, provided that the INR is between 2 
and 4.
The study presented by Blinder et al. (17) on 150 pa-
tients, compares three local measures for controlling 
bleeding. All of the patients continued treatment with 
OACs and the INR value ranged between 1.5 and 4 on 
the day of the procedure. The first group used gelatin 
sponges and sutures; in the second group, gelatin spong-
es, suture and traneximic acid mouth rinses were used 
4 times per day; and in the third group, gelatin sponges, 
fibrin glue and sutures were used. The results showed 
that 11 patients presented post-operative bleeding—
equally distributed among the three groups, which was 
controlled by curettage of the alveolus, replacing the 
fibrin sponges or fibrin glue and resuturing the wound. 
None of the patients required a hospital stay. 
Martinowitz et al. (9) studied 40 patients, in which a 
total of 63 extractions were performed, without alter-
ing the dose of OAC. Hemostasis was achieved with a 
biological adhesive after placing gauze moistened with 
thrombin in the alveolus for a period of three minutes. 
On the day of the procedure, the INR value ranged bet-
ween 2.5 and 4. There were no significant episodes of 
post-operative bleeding. Only one patient presented 
bleeding on the third day of the post-operative period, 
which was controlled by applying pressure with gauze. 
In contrast, in the study by Carter et al. (16), two local 
methods for controlling bleeding were compared: irri-
gation of the alveolus with tranexamic acid and place-
ment of autologous fibrin glue. On the day of the pro-
cedure, the INR ranged between 2 and 4. The results 
showed that two patients presented significant bleeding, 
included in the group that used fibrin glue, 2 days after 
the procedure, presenting an INR value of 5.9 and 7.6, 
and thus, the local measures were not sufficient, requi-
ring the doctor to adjust the dose of OAC.
In addition, in the study presented by Morimoto et al. 
(15), in which they performed extractions on patients 
with an INR value of less than 3, four patients required 
modifying the dose of OAC and one of them required 
taking vitamin K, given that on the day of the bleed-
ing—between 2 to 6 days post-extraction—the INR 
value had exceeded 3.5. The local measures taken to 
control the bleeding consisted of oxidized cellulose and 
sutures.
Given all of the aforementioned reasons, continuing 
with the oral anticoagulant therapy when undergoing a 
dental extraction would be justified as long as the INR 
value is within the therapeutic range, given that the risk 
of uncontrollable bleeding is relatively low and does not 
justify the risk of thromboembolism. However, main-
taining the INR value under control is rather compli-
cated, given that treatment with OACs is quite sensitive 
to multiple factors such as diet, minimal changes when 
taking the tablets and the interactions of different me-
dicines (2,12).
Despite the fact that several authors advise against ex-
traction with INR values above 4, there are studies (8, 
11-13) that include patients with INR values above this 
number. A study published by Blinder et al. (19) on 249 
patients who were grouped according to their INR va-
lues, did not find a correlation between the INR value 
and the incidence of bleeding during the post-operative 
period, even in patients who had an INR value greater 
Med Oral Patol Oral Cir Bucal. 2011 Sep 1;16 (6):e800-4.                                                                                                                                                    Oral anticoagulants and dental extraction
e804
 References with links to Crossref - DOI    than 4.  They concluded that the INR value alone will 
not predict the risk of post-extraction bleeding, rather 
this value must be taken into consideration along with a 
careful evaluation of the risk of bleeding / thromboem-
bolism that each patient  presents and a detailed exami-
nation of each patient’s clinical history.
In order to obtain optimum conditions for limiting the 
intra and post-operative bleeding as much as possible, 
an effort must be made during the pre-surgery phase to 
quantitatively reduce the irritants and reduce inflamma-
tion of the soft tissues. Patients must maintain proper 
hygiene of the oral cavity one week before the proce-
dure, including supragingival tartrectomy, if required 
(12), prescribing mouth rinses with clorhexidine twice 
per day for a period of 7 days.
With regard to performing a correct surgical technique, 
all of the authors describe an extraction that is as a-
traumatic as possible, such as that described by Scully 
et al. (2) and Evans et al. (13). If a flap must be lifted, it 
must always be the mucoperiostic flap, and stress on the 
flap must be minimized. When an odontosection and 
ostectomy must be performed, it must be done by con-
serving the cortical bone in order to aid coagulation of 
the wound. A careful and meticulous curettage of the 
alveolus must be performed in order to eliminate the 
inflammatory and granulation tissue, considering this 
to be a key step to minimize bleeding in the wound, 
placement of fibrinogenous elements and suturing the 
wound to ensure the primary closure.  As far as gauze 
compression is concerned, there are authors who con-
sider that the gauze must be moistened with fibrinogen 
(7,13,16) and others that affirm that this is only nece-
ssary if gauze compression alone is not sufficient. In ac-
cordance with the data obtained in this study, placing 
fibrinogen inside of the alveolus (fibrin glue, oxidized 
cellulose, etc.) is not entirely necessary, given that mois-
tening the gauze with tranexamic acid and compression 
is already sufficient for obtaining hemostasis.
There are numerous protocols for describing the post-
operative care that the patient must follow. Some authors 
such as Carter et al. (7) recommend mouth rinses with 
tranexamic acid. In contrast, Ferrieri et al. (12) consider 
that mouth rinse increases the risk of dissolving the 
coagulant, compared to the benefit that is obtained by 
the fibrinogen substance, ultimately concluding that 
this procedure must be omitted. The patient must also 
be instructed not to touch the wound or make suctions 
with the tongue (2,4). Following the post-operative care 
instructions must be emphasized, given that in some 
cases, the occurrence of bleeding several days after the 
procedure is caused as a result of the patient not fol-
lowing the post-operative care instructions properly 
(7,10,12), in which case the patient must be reminded of 
the instructions and the importance of following them.  
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